Aerovate Therapeutics Inc (AVTE) — Strategic Asset Allocation Index
Aerovate Therapeutics Inc (AVTE) has a Strategic Asset Allocation Index of 0.2% as of June 2023. Strategic assets (PP&E of $245.00K plus long-term investments of $-) total $245.00K, measured against net assets of $141.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Aerovate Therapeutics Inc Strategic Asset Allocation Index (2021–2021)
This chart shows how Aerovate Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 0.2%, representing strategic assets of $245.00K against net assets of $141.93 Million USD. Explore AVTE cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Aerovate Therapeutics Inc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Aerovate Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Aerovate Therapeutics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.4% | $728.00K | $728.00K | $- | $172.42 Million | — |